Literature DB >> 8709273

Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance.

I S Novella1, M Cilnis, S F Elena, J Kohn, A Moya, E Domingo, J J Holland.   

Abstract

Vesicular stomatitis virus (VSV) populations were repeatedly passaged in L-929 cells treated with alpha interferon (IFN-alpha) at levels of 25 U/ml. This IFN-alpha concentration induced a 99.9% inhibition of viral yield in standard infections. Analysis of viral fitness (overall replicative ability measured in direct competition with a reference wild-type VSV) after 21 passages in IFN-treated cells showed only a limited increase or no increase in fitness, compared with the greater increase upon parallel passage in cells not treated with IFN-alpha. However, this limited increase in fitness was more pronounced when competition assays were carried out with IFN-alpha-treated cells, suggesting the selection of VSV populations with a low level of resistance to IFN-alpha. Thus, despite the extensively documented capacity of VSV to adapt to changing environments, the antiviral state induced by IFN-alpha imposes adaptive constraints on VSV which are not readily overcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709273      PMCID: PMC190671          DOI: 10.1128/JVI.70.9.6414-6417.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

Review 1.  Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents.

Authors:  E Domingo; J J Holland
Journal:  Genet Eng (N Y)       Date:  1992

Review 2.  RNA virus populations as quasispecies.

Authors:  J J Holland; J C De La Torre; D A Steinhauer
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 3.  Mutations and A/I hypermutations in measles virus persistent infections.

Authors:  R Cattaneo; M A Billeter
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 4.  Genetic diversity and evolution of retroviruses.

Authors:  J M Coffin
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 5.  Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo.

Authors:  S Wain-Hobson
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 6.  Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities.

Authors:  C E Samuel
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

7.  Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase.

Authors:  S Gunnery; A P Rice; H D Robertson; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; L Murray; J Waggoner; Z Goodman; S M Banks; J H Hoofnagle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

9.  Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet.

Authors:  E Duarte; D Clarke; A Moya; E Domingo; J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

10.  The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2.

Authors:  M V Davies; O Elroy-Stein; R Jagus; B Moss; R J Kaufman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  8 in total

1.  Diminishing returns of population size in the rate of RNA virus adaptation.

Authors:  R Miralles; A Moya; S F Elena
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.

Authors:  I M Rouzine; A Rodrigo; J M Coffin
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  Emergence of mammalian cell-adapted vesicular stomatitis virus from persistent infections of insect vector cells.

Authors:  Isabel S Novella; Bonnie E Ebendick-Corpus; Selene Zárate; Eric L Miller
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

Review 4.  Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution.

Authors:  Bram Van den Bergh; Toon Swings; Maarten Fauvart; Jan Michiels
Journal:  Microbiol Mol Biol Rev       Date:  2018-07-25       Impact factor: 11.056

5.  Inhibition of enveloped virus infection of cultured cells by valproic acid.

Authors:  Angela Vázquez-Calvo; Juan-Carlos Saiz; Francisco Sobrino; Miguel A Martín-Acebes
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

Review 6.  The evolution of RNA viruses: A population genetics view.

Authors:  A Moya; S F Elena; A Bracho; R Miralles; E Barrio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

7.  Interferon induction as a quasispecies marker of vesicular stomatitis virus populations.

Authors:  P I Marcus; L L Rodriguez; M J Sekellick
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Plasma membrane phosphatidylinositol 4,5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus.

Authors:  Angela Vázquez-Calvo; Francisco Sobrino; Miguel A Martín-Acebes
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.